Rhabdomyolysis Associated with Concomitant Use of Atorvastatin and Cyclosporine

Abstract

Similar to other members of the HMG-CoA reductase inhibitor class, atorvastatin may interact with cyclosporine and potentially result in rhabdomyolysis. Clinicians should be aware of this possible drug interaction and carefully monitor patients receiving these two drugs concomitantly.